Relay Therapeutics


Need for expert finance and accounting leadership and management from launch to initial funding to eventual IPO.


Relay Therapeutics needed cost-effective accounting and finance operations

and CFO-level insights as it moved from fast-growing startup to preparing for an IPO. It also needed a solid fundraising strategy.


TechCXO supported the firm with distinct CFO and other accounting resources to manage all finance and accounting activities from startup to preparing the company for its eventual IPO. TechCXO Managing Partner Chris Thomajan became an integral member of the leadership team, providing thoughtful advice based on years of experience in building biotech companies. He interacted with our Board of Directors and investors on a regular basis.


Relay Therapeutics had a successful IPO in July of 2020. (NASDAQ: RLAY)

“Chris worked with the original Third Rock Ventures team and helped launch Relay in 2015. He and his team at TechCXO built the foundation of the finance function and prepared the company for the Series B financing. In this launch phase Chris became a trusted member of the initial management team and his ability to share experiences from many other start-ups he had worked on was very valuable.. As the company started to grow rapidly in 2018, Chris helped hire our full-time finance staff. Relay launched its IPO in July of 2020.”

Sanjiv PatelChief Executive Officer

Relay Therapeutics, Inc.


For more information, contact TechCXO Managing Partner Chris Thomajan.